Cabochon Aesthetics, Inc. (extinct)

Cabochon Aesthetics, Inc. (extinct)

Cabochon Aesthetics, Inc. (extinct)

Overview
Date Founded

2005

Headquarters

127 INDEPENDENCE DRIVE MENLO PARK CA 94025

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Medical Products & Equipment
Appliances & Electronics
Computer Software
Computer Hardware
Hospitals & Patient Services

Company Description

Cabochon Aesthetics, Inc. offered scientific solutions for aesthetic procedures. Its also provided noninvasive fat removal and cellulite treatment. The company was founded on January 12, 2005 and was headquartered in Menlo Park, CA.

Executives & Employees

Co-Founder

Paths to Cabochon Aesthetics, Inc.
Potential Connections via
Relationship Science
You
Cabochon Aesthetics, Inc.
Recent Transactions
Details Hidden

Ulthera, Inc. purchases Cabochon Aesthetics, Inc.

Details Hidden

Cabochon Aesthetics, Inc. raised money in a private placement transaction

Details Hidden

Cabochon Aesthetics, Inc. raised money in a private placement transaction

Transaction Advisors
Escrow Agent

Advised onUlthera, Inc. purchases Cabochon Aesthetics, Inc.

Legal Advisor

Advised onUlthera, Inc. purchases Cabochon Aesthetics, Inc.

Legal Advisor

Advised onUlthera, Inc. purchases Cabochon Aesthetics, Inc.

Legal Advisor

Advised onUlthera, Inc. purchases Cabochon Aesthetics, Inc.

Investors
Details Hidden

Split Rock focuses on leading investments in early-stage medical device companies. They also consider investments in select life sciences opportunities in which they can facilitate additional growth, spin-outs or restructurings. The firm seeks companies with significant market size, usually greater than $500 million.They also look for companies operating in target markets that have the potential to reach over $1 billion over time. Companies should be able to generate $100 million in revenue within 5 years and have gross margins greater than 50%, potential operating margins greater than 20%, recurring revenue streams, capital-efficient growth plans, efficient methods of customer acquisition and sustainable competitive advantages.Split Rock invests Internet and software-driven companies with products that are delivered as on-demand services, premise-based software and appliances. The firm is particularly interested in web-based business and consumer services, marketing automation, enterprise analytics, real-time information services and enterprise infrastructure.

Details Hidden

Prospect Venture Partners focuses on investments in commercially attractive biomedical technology and life science companies that have management teams, proprietary products and innovative technology or services. They participate in new company incubations,seed, first and second venture financing rounds and expansion capital financings of later-stage private and public companies with proven business models. Initial investments range from $500,000 to $10 million with $10 million to $20 million invested over the life of a company. Prospect Venture Partners will serve as a lead investor or as a co-lead in a syndicate. The firm typically takes a seat on the boards of their portfolio companies.

Details Hidden

Morgenthaler Ventures specializes in traditional MBOs, leveraged recapitalizations, industry build-ups and growth equity investments in the lower middle-market. The firm targets high-value manufacturing and outsourced business services companies. They look for industry-leading companies with transaction values of $25 million to $250 million and EBITDA of $5 million to $40 million. Morgenthaler seeks to invest in profitable, stand-alone companies and in divisions or subsidiaries of larger corporations. The firm participates in traditional MBOs, leveraged recapitalizations, industry build-ups and growth equity investments. For strategic platform investments Morgenthaler focuses on investments in North American companies. They consider add-on acquisitions globally. Morgenthaler Ventures focuses on the information technology and life sciences sectors. Within the information technology sector, the firm is particularly interested in consumer services, mobile computing, software/services, systems/semiconductors and energy. Investments range from $5 million to $15 million per company over several rounds. Initial investments may be as small as $500,000. The majority of their information technology investments are Series A rounds but the firm also considers later-stage opportunities. Morgenthaler Ventures invests in a variety of life science companies with a particular emphasis on therapeutic biopharmaceuticals, medical devices and healthcare services. Investments in biotechnology companies range from $12 million to and $20 million over several rounds. Investments in medical device companies range from $10 million to $12 million. Most of these investments are in Series A rounds, but the firm also considers later-stage opportunities.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cabochon Aesthetics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cabochon Aesthetics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cabochon Aesthetics, Inc..